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S1.a. Synthesis of Rf-OTs: A 500-mL, three-necked, round-bottomed flask fitted with a stirrer and a 
thermometer is charged with 200 mL of pyridine and 18.81 g (0.05 mol) of Riboflavin (Rf) in 200 mL of 
DMSO. The solution is stirred and chilled to 0°C and then 9.53 g (0.05 mol) of freshly recrystallized p-
toluenesulfonyl chloride is added in portions over a 20-min period. The reaction mixture is allowed to 
attain room temperature and is stirred for 16 H. The mixture is re-cooled to 0°C and poured into 100 mL 
of concentrated hydrochloric acid in 500 mL of ice water. The aqueous layer is extracted with 100 mL of 
DCM and the combined organic layers are washed with two 60-mL portions of brine, dried over 
magnesium sulphate and concentrated by rotary evaporation to yield 10.2 g of a light yellow solid of Rf-
OTs.  
S1.b. Synthesis of RfSH: Rf-OTs, 10.61 g , 0.02 mol is dissolved in ether (100.0 ml) by continuous 
stirring and then 1,2-dithiane (2 g, 0.02 mol) is added in drop wise manner. The reaction mixture is stirred 
for 24 H in presence of catalytic amount of NaI (0.003 g, 0.00002 mol) under room temperature. The dark 
yellow product is purified using column chromatography and used as RfSH. The solid product is 
separated out and then crystallized in hot ethanol-water mixture that produces a pale yellow coloured 
solid (m.p.195 °C) of RfSH (~39%). 
 
 
  
1
H NMR (300 MHz, DMSO-d6) δ, ppm= 11.34 (s, 1H, N12-H), 7.92 (s,1H, Ar-C1-H), 7.88 (s,1H, Ar-
C4-H),  5.15 (s, N14-H), 4.59 (s, N8-H), 4.93, 4.90, 4.87, 4.8 (m, 1H, 1H, C18, 20-H), 4.80, 4.79 (d, 2H, 
C17-H), 4.63, 4.59 (d, 2H, C21-H), 3.47, 3.45, 3.43 (t, 1H, C19-H), 2.675, 2.671, 2.66, 2.64 (m, 2H, C24-
H), 3.63 (s, 1H, 3-OH), 2.58 (s, 1H, S25-H). 2.57-2.50 (m, 2H,C23-H), 2.48 (s, 3H, C15-H), 2.40 (s, 3H, 
C16-H).  
13
C NMR (75 MHz, DMSO-d6): 117.5(C1,C4), 135.7(C2), 136.7 (C3)150.8(C6), 146.1(C7), 132.1 (C9), 
134.0(C10), 155.6 (C11), 160.0 (C13), 18.8 (C15,C16), 47.36 (C17), 63.4 (C18), 68.8(C19), 72.8 (C20), 
73.6(C21), 40.3(C23), 38.2(C24). 
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FigS1: (A)
 1
H
 
  and (B) 
13
C NMR spectra of RfSH.  (C) ESI mass spectrum of RfSH. 
m/z obtained  for RfSH is : 454.16 [Exact mass 454.13] 
S1.c. Preparation of citrate capped gold nanoparticles (CAuNPs): (Turkevich et al., 1951) 
To a aqueous solution of HAuCl4, 3H2O (1M, 0.5 ml), autoclaved Millipore water (18.5 ml) is added and 
boiled for 2 minutes. To this boiling yellow solution Trisodiumcitrate (10
-2
M, 0.5ml) is added drop wise. 
The color of the previous yellow solution of gold chloride turned into wine red. The Plasmon of the 
prepared gold sol is measured using absorption spectrophotometer ( max= 525nm).      
S1.d. Preparation of RfS@AuNPs: 
Aqueous solution of RfSH (510-4 M) is mixed with 1 nM CAuNPs in 1:4 ratio. Resulting solution is 
kept for  4 H and centrifuged (at 4000 rpm) for 90 minutes. This process is repeated thrice. The bottom 
part is collected, redispersed in water and used as RfS@AuNPs for experiments. The concentration of 
RfS@AuNPs used for cell treatment is 0.5 nM . 
 
C 
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S1.e. Preparation of Rf@AuNPs: 
Aqueous solution of Rf (510-4 M) is mixed with 1 nM CAuNPs in 1:4 ratio. Resulting solution is kept 
for  4 H and centrifuged (at 4000 rpm) for 90 minutes. This process is repeated thrice. The bottom part is 
collected, redispersed in water and used as Rf@AuNPs for each experimental step. The concentration of 
Rf@AuNPs used for cell treatment is 0.5 nM . 
S2. Materials and Methods: 
S2.a. Reagents and General Methods 
All the chemicals and solvents required for syntheses of the thiol derivative of Riboflavin are of analytical 
grade. We have purchased 7,8-Dimethyl-10-[(2S,3S,4R)-2,3,4,5-Tetrahydroxypentyl]benzopteridine-2,4-
dione (Riboflavin), 1,2-Ethanedithiol, from Aldrich Chemical Co., highly polymerized calf thymus DNA 
(CT-DNA) from Sisco Research Laboratory, India, and tris buffer, sodium chloride and hydrochloric acid 
(AR) from Merck and used without further purification. Triple distilled water has been used for the 
preparation of all the aqueous solutions. Solvents required for syntheses and spectroscopic studies have 
been purchased from SRL, India and Spectrochem, India respectively. HAuCl43H2O, trisodiumcitrate has 
been procured from Sigma. All the solvents have been purchased from commercial sources and distilled. 
Triple distilled deionized water has been used for all the experiments. 
S2.b. Absorption and fluorescent measurements: 
Steady-state absorption and fluorescence spectra of Rf are recorded by using JASCO V-650 absorption 
spectrophotometer and Spex Fluoromax-3 Spectro-fluorimeter respectively using a 1.0 cm path length 
quartz cuvette. For a given sample, the wavelength at which absorbance is maximum (max) is used as 
excitation wavelength for corresponding emission scan.  
The fluorescence lifetime measurement is performed using a picosecond pulsed diode laser based TCSPC 
fluorescence spectrometer with ex = 377 nm and MCP-PMT as a detector. The emission from the 
samples is collected at right angle to the direction of the excitation beam maintaining magic angle 
polarization (54.7•) with a band pass of 2 nm. The full width at half maximum (FWHM) of the instrument 
response function is 270 ps and the resolution is 28 ps per channel. The data are fitted to exponential 
functions after deconvolution of the instrument response function by an iterative reconvolution technique 
using data analysis software in which reduced ϰ2 and weighted residuals serve as parameters for better fit. 
All the steady-state and time-resolved measurements are performed at room temperature (298 K). 
S2.c. Laser-flash photolysis: 
 Transient intermediates are generated with third harmonic (355 nm) output of nanosecond flash 
photolysis set-up (Applied Photophysics) containing Nd:YAG Laser (Lab series, Model Lab 150, Spectra 
Physics). A full width half maximum of the exciting laser is ~8 ns. Transient species in solution are 
detected through absorption of light from a pulsed xenon lamp (150 W) at right angle to the laser beam. 
The wavelength from the probe beam is dispersed with a monochromatic and detected with a 
photomultiplier detector (R928). The photomultiplier output is fed into an Agilent Infiniium oscilloscope 
(DSO8064A, 600 MHz, 4 Gs/s) and the data are transferred to a computer using IYONIX software. The 
detail of the experimental set-up is explained elsewhere. The software ORIGIN 8.0 is used for curve 
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fitting. The solid curves are obtained by connecting the points using B-spline option. The samples are 
deaerated by passing pure argon gas for 20 min prior to each experiment. No degradation of the sample is 
observed during the experiment. 
S2.d. Transmission Electron Microscopy (TEM): TEM measurements have been carried out using an 
FEI, TECNAI G2F30, S-TWIN microscope operating at 300 kV equipped with a GATAN Orius 
SC1000B CCD camera. The diameter is analyzed manually by modeling each AuNP as a sphere, with 
statistical analysis using Image J software on populations of greater than 100 particles. 
S2.e. Confocal microscopic data: 
Hela cells are grown on coverslips in DMEM medium and treated with 0.5nM of different drug@AuNP 
(drug = Rf/RfSH) at different time points (6 H, 18 H and 24 H). After treatment the cells are fixed with 
4% paraformaldehyde and washed with 1X PBS. Then slides are prepared with these cover slips using 
DAPI containing mounting media. Double stranded breaks in treated cells are detected by staining with 
anti -H2AX antibody (Abcam ) at a dilution of 1:500. 
For live cell experiment, Hela cells are cultured on 35 mm glass bottom petri dish (Genetix) in DMEM 
medium. Next day cells are treated with RfS@AuNPs at a concentration of 5M for 6 H. After treatment 
the medium is changed freshly and live cell imaging is set up in an attached humid chamber (Tokai Hit, 
Japan) at 37
0
C with 5% CO2. Images are acquired at 30 min interval for next 18 H.  
All microscopic images are acquired with Nikon’s inverted confocal microscope where A1R+ confocal 
scanner head is mounted on Eclipse Ti-E microscope using 100X objective (oil immersion; NA 1.4). 
Nuclei are imaged using DNA binding dye DAPI with 405 nm laser. RfS@AuNPs are detected using 488 
nm laser as the compound has excitation maximum at 444 nm. For detecting double stranded breaks the 
anti--H2AX primary antibody is hybridized with secondary antibody conjugated with Alexa Fluor 594 
(1:1000) and detected using 561 nm laser.         
S2.f. Flow cytometry analysis 
HeLa cells (untreated and Rf@AuNPs, RfS@AuNPs treated) are rinsed with PBS, trypsinized, pelleted, 
rinsed again in PBS, fixed in double volume of cold ethanol and stored at -20 °C for 2 H. Then the cells 
are rinsed with PBS, resuspended in 500 μl of PBS, treated with RNase (0.2 µg/µL at 37 °C for 30 
minutes) followed by propidium iodide staining (0.05 µg/µL for 1 H at 37 °C) and subjected to flow 
cytometry on a FACS Calibur from BD Biosciences. Ten thousand events are collected in each run. Data 
are analyzed using Cell Quest software.   
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S3. Absorption spectra of RfSH /Rf in presence CAuNPs: 
The citrate capped colloidal gold nanoparticles (CAuNPs) have characteristic wine red color originating 
from the coherent electron motion. The plasmon band at 525 nm in the UV–Vis spectrum is characteristic 
of gold nanoparticles as depicted in Fig S2. In ground state (5 10-6 M) riboflavin (Rf) and RfSH in water 
show two absorbance maxima in Fig S2 [368 nm and 444 nm]. With increase in concentration of 
nanoparticles (0.25→1.5nM), the absorbance (O.D.) gradually increases around 525 nm in case of Rf 
without formation of any new peak due to the lack of ground state interaction between CAuNPs and Rf. 
That is no significant change occurs in the surface plasmon of the [CAuNPs] in Rf solution. With 
increasing [CAuNPs] (0.25→1.5 nM) in a fixed RfSH solution the absorption maxium slightly shifts 
from 525 nm to 529 nm. 
.   
Figure S2:  Absorption spectra of (A) Rf (5 10-6 M) in H2O with increasing concentration 
AuNPs (0.25→1.5nM) in water.(B) Absorption spectra of RfSH (5 10-6M) in H2O with 
increasing concentration of AuNPs (0.25→1.75nM). 
 
S4. Quantification of RfSH attachment per AuNP: 
This experiment is performed to measure the amount of average drug molecule attached to an AuNP. The 
O.D of (Fig S3A) Rf (5 10-6M) + AuNP (0.25nM) and (Fig S3B) RfSH (510-6M) + AuNP (0.25 nM) 
in water are recorded first. Then the resulting solutions are centrifuged at 4500 rpm for 2 H. The upper 
part of the solution is then collected and O.D for the same is measured. The same process is performed for 
only Rf and RfSH (5 10-6 M) for negative control. 
For both the cases the plasmon for the gold (525 nm) totally disappears after centrifugation and the O.D 
of the Rf (368 nm and 444 nm) deceases (0.03) (fig. S3A) while for Rf-SH the decrease in O.D is 0.147 
(5 times as compared to Rf) (fig. S4B). No change is observed for the case of only Rf and RfSH (5 10-
6
M) [Inst Fig.S3].  
(B) 
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These observations indicate that Rf and RfSH get adhered on the surface of gold nanoparticles. As a 
result after centrifugation those conjugates (Rf + AuNP and RfSH + AuNP) get precipitated which is 
reflected through the absence of AuNP plasmon. Since the SH group has stronger affinity for AuNP, the 
amount of RfSH conjugated to AuNP is about 5 times greater as compared to Rf.      
Again from the above experimental data (i.e. decrease in O.D) it is calculated that  4680 number of Rf 
ligands and 22800 number of RfSH ligands are attached with one gold nanoparticle (AuNP is assumed 
to be spherical with 20 nm average diameter proved latter by TEM image (Fig. S4). 
 
Note: For Rf and RfSH: All the experiments with Rf and RfSH are reported here according to 
fluorophore concentration (in μM range). 
For Rf@AuNPs and RfS@AuNPs: All the experiments with Rf@AuNPs and RfS@AuNPs are reported 
here according to nanoparticle concentration (in nM range) 
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Figure S3: Absorption spectra of (A) Rf (5  10-6M) (B) RfSH (5  10-6M) in water with CAuNPs 
(0.25nM); (Inset spectra are of control i.e only Rf and RfSH without CAuNP) before and after 
centrifugation. 
S5: Transmission Electron Microscopy (TEM) of Different Gold Nanoparticles.  
 
    
                                         (A)                                                            (B) 
Figure S4. Transmission electron micrographs of (A) Rf@AuNPs (B) Citrate capped gold 
nanoparticles (CAuNPs). 
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S6 Fluorescence Data: 
The AuNP is non fluorescent. The fluorescence maximum (max) of Rf is at 524 nm which is 
close to absorption wavelength of AuNP (max = 525nm). Therefore, the emitted energy of Rf 
and RfSH might be getting absorbed by AuNPs. Therefore with the gradual increase of AuNP 
concentration (0.25→1.5 nM), this sort of energy transfer might be responsible for quenching of 
fluorescence intensity of Rf.  
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Figure S5:  Fluorescence spectra of (A)Rf (5×10
-6
M) (B) RfSH (5×10
-6
M) in water with 
increasing concentration of AuNPs (0.25→1.5nM); (ex = 444 nm)  
S7 Study of time-resolved fluorescence: 
The fluorescence lifetime of Rf is 4.73 ns and that of RfSH is 4.69 ns in aqueous medium. 
Moreover the lifetime of Rf and RfSH in aqueous medium remain unaltered with the addition of 
the gold nanoparticles (checked upto addition of 1nM). This reflects that the quenching in 
fluorescence emission is of static type and that is due to the formation of ground state complex of 
Rf or RfSH with CAuNPs.  
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Figure S6: Time-resolved fluorescence decay spectra of (A) Rf (5×10-6M) (B) RfSH (5×10-6M) in 
water with gradual increase in concentrations of Gold nanoparticles (0.25→1nM) (ex =377 nm) 
S8: DNA Intercalation study: 
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Figure S7: Absorption spectra of   10 µM DNA in Tris-buffer titrated with increasing 
concentration of (a) Rf@AuNPs (b) Rf (c) RfSH 
 
S9. Determination of Drug-DNA Binding Strength from Steady-State Emission Spectral 
Data: 
Calf Thymus - DNA (ct-DNA) itself is non fluorescent. Upon excitation (ex = 444nm) 
isoalloxazine moiety of Rf emits at 525 nm. A regular enhancement of the fluorescence intensity 
with the gradual addition of ct-DNA is observed for both Rf and RfSH. With the addition of 
AuNPs the fluorescence emission intensity is quenched (shown in the Figure S7). With further 
addition of AuNPs the intensity of ct-DNA is again enhanced and even becomes greater than the 
intensity of RfSH alone. When isoalloxazine moiety of Rf intercalates DNA by stacking 
interaction among the base pairs, it enters in more constrained environment which prevents the 
nonradiative decay process, thus the enhanced fluorescence intensity is observed. Again the 
binding constant calculated for RfS@AuNPs (Kb=1.110
4
) is greater than that for RfSH 
(Kb=2.810
3
).  
 
S-16 
 
450 500 550 600 650 700
0.0
0.3
0.6
0.9
1.2
1.5
1.8
 
F
l.
 I
n
t.
(a
.u
.)
Wavelength(nm)
 
 RfSH
 RfSH+10µM DNA
 RfSH+15µM DNA
 RfSH+20µM DNA
 RfSH+25µM DNA
 RfSH+30µM DNA
 RfSH+35µM DNA
 RfSH+40µM DNA
 RfSH+45µM DNA
 RfSH+50µM DNA
(A)
 
 
450 500 550 600 650
0.0
0.3
0.6
0.9
1.2
1.5
1.8
(B)
F
l.
In
te
n
s
it
y
(a
.u
.)
Wavelength(nm)
 RfSH
 RfS@AuNPs+10µM DNA
 RfS@AuNPs+s15µM DNA
 RfS@AuNPs+20µM DNA
 RfS@AuNPs+25µM DNA
 RfS@AuNPs+30µM DNA
 RfS@AuNPs+35µM DNA
 RfS@AuNPs+40µM DNA
 RfS@AuNPs+45µM DNA
 RfS@AuNPs+50µM DNA
 
 
S-17 
 
10 15 20 25 30 35 40 45 50 55
-0.21
-0.18
-0.15
-0.12
-0.09
-0.06
-0.03
 
 
lo
g
(F
-F
0
/F
)
 
 
[DNA]M
I 0
-I
/I
 RfSH+DNA
RfS@AuNPs+DNA
(C)
 
  
Figure S8: Emissions spectra of (A) RfSH (5×10
—6 
M) (B) (0.5nM) RfS@AuNPs (ex=444nm) 
in tris-buffer with increasing concentration of ct-DNA (10→50 µM ) (ex=444nm).(c) Stern-
Volmer plot for comparative enhancement of intensity and binding constant. 
S10 .Circular dichroism (CD) studies: 
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Figure S9: CD spectra of ct-DNA in Tris-buffer titrated with increasing concentration of (A) Rf (B) 
RfSH (1µM-7 µM) (C) [Rf@AuNPs] 0.1 nM-0.7 nM 
S-19 
 
S11. Laser Flash photolysis: DNA intercalation:  
Triplet-triplet absorption of RfS@AuNPs shows peak around 360 nm and 530 nm in tris-buffer. It is 
observed that with the gradual addition of DNA the overall absorbance of RfS@AuNPs drops off along 
with a comparable decrease in the lifetime (Ƭ) of the transients at 360 nm and 530 nm from 2.8→2.1 µS 
and 2.9→2 µS respectively.This quenching occurs may be due to inaccessibility of isoalloxazine ring 
which is stacked within the DNA microenvironment. Again with the gradual increase in DNA 
concentration, the ground state interactions of DNA with RfS@AuNPs hamper the overall inter system 
cross over process. Hence triplet yield of RfS@AuNPs decreases. This data again support the hypotheses 
of ground state interaction between RfS@AuNPs and DNA.     
 
S12:  Flow cytometric Data (FACS) data: 
 
Figure S10A: Cell cycle affected by Rf@AuNP. 
A 
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Figure S10B: Cell cycle affected by RfS@AuNPs. 
 
 Figure S10C: Cell cycle of Untreated HeLa cells (Control). 
B 
C 
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We have quantified the nuclear and cytosolic distribution of Rf@AuNPs and RfS@AuNPs at each time 
point of the confocal images. We observe a preference of RfS@AuNPs for nuclear localization which 
peaks at 24 H time point, unlike Rf@AuNPs. The intensity of green color is found to be increased 
significantly from cytoplasm to nucleus with increasing incubation time as shown in Figure S11. 
However, the same phenomenon is not significant in case of Rf@AuNPs treatment (Figure S11). 
 
 
FigureS11: Relative green intensity within cytoplasm and nucleus for RfS@AuNP and Rf@AuNP 
(control) treated cells in different incubation time; [Intensity analysis is done based on the average of 4 
cells’ nucleus from each frame using ‘Mathematica’ software] 
pH stability of RfS@AuNPs: 
We are unable to check the pH stability of RfS@AuNPs within lysosomes and endosomes. However, we 
have performed stability assays of RfS@AuNPs at different pH employing fluorescence spectroscopy. 
The pH within the lysosome is around 5.0-5.5. Therefore, we have attempted to investigate the pH 
stability of RfS@AuNPs in vitro. The complex is dissolved in tris-buffer with pH 5.0, 7.2 and 8.5 and 
incubated for 12 H. Then, the resulting solutions are centrifuged at 4500 rpm for 2 H. The bottom part 
which contains RfS@AuNPs is collected and washed to remove free RfSH and resuspended into 
respective buffers. We have checked the corresponding fluorescence spectrum with the resuspended 
conjugates in buffer having three respective pH (Figure S12).  If the nano conjugate becomes unstable in 
acidic pH, the intensity of the resuspended solution should decrease due to breaking of complexation from 
AuNPs with subsequent release of RfSH in the buffer before centrifugation. However, no such significant 
decrease in fluorescence intensity is observed in case of resuspended solution. The above experiment 
indicates that the nanoconjugate is quite stable at pH 5.0. Similar results may be obtained in lysosomal 
environment where pH is around 5.0. Moreover, the resuspended solutions with two other pH follow the 
same trend indicating that RfS@AuNPs is also stable at pH 7.2 and 8.5.  
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Figure S12: Relative fluorescence intensity of the RfS@AuNPs in tris buffer with different pH, 5.0, 7.2 
and 8.5 before and after resuspension. 
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Figure S13: Volcano Plot: There are 9373 differentially expressed genes in  RfSH@AuNP Treated vs. 
Control, where 4054 are Up regulated genes and 5319 are Down regulated genes at Fold change >=1.1 
and P Value <=0.05. 
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Figure S14: PANTHER analysis of cellular processes altered by RfSH@AuNP treatment. A and B. 
Gene Ontology (GO) analyses of changes in significant biological processes; (C) Significant changes in 
cell signaling pathways. 
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